Immediate Impact
14 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Osman Öcal being referenced
Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective study
2022
Prognostic value of baseline imaging and clinical features in patients with advanced hepatocellular carcinoma
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Osman Öcal | 113 | 81 | 61 | 56 | 260 | |
| Xiaofeng He | 96 | 105 | 62 | 45 | 319 | |
| Sameer Gadani | 76 | 121 | 59 | 33 | 281 | |
| Gehad A. Saleh | 69 | 60 | 43 | 38 | 300 | |
| Shunsuke Sugawara | 77 | 150 | 121 | 55 | 304 | |
| Ali Bohlok | 63 | 107 | 45 | 31 | 233 | |
| Alice Fung | 95 | 102 | 61 | 34 | 289 | |
| Aaron Kian Ti Tong | 71 | 55 | 73 | 34 | 226 | |
| Dominik Sieroń | 62 | 101 | 54 | 35 | 277 | |
| Ashraf Anas Zytoon | 100 | 62 | 35 | 27 | 276 | |
| Renato Argirò | 77 | 106 | 100 | 41 | 294 |
All Works
Loading papers...